Clindamycin Hydrochloride Capsule
Product Images NDC 72789-180

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Clindamycin Hydrochloride (NDC 72789-180). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Pd-rx Pharmaceuticals, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

72789180 Label (72789180)

72789180 Label (72789180)
This is a medication label for Clindamycin capsules, each containing 150 mg of clindamycin hydrochloride equivalent to be taken multiple times a day. There are 28 capsules in the package with lot numbers C21F6S, C21RES, CA1F65 and an expiration date of 03/2023. Patients should continue taking the medication unless advised otherwise by their doctor and should call their doctor for any medical advice about side effects. The label also provides information on how to report side effects to the FDA. The manufacturer is D-Pharmaceuticals Incorporated based in Oklahoma City, OK.*
FDA Label Image

Structure (Clindamycinhclstructure)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.